应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARWR Arrowhead Research Corporation
盘前交易 12-19 05:45:14 EST
20.36
-1.91
-8.58%
盘前
20.89
+0.53
+2.60%
04:33 EST
最高
22.28
最低
20.12
成交量
139.96万
今开
22.27
昨收
22.27
日振幅
9.70%
总市值
25.33亿
流通市值
22.53亿
总股本
1.24亿
成交额
2,921万
换手率
1.26%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.36%报23.49美元
市场透视 · 12-06
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.36%报23.49美元
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.18%
市场透视 · 12-05
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.18%
Arrowhead Pharmaceuticals, Inc.2024财年实现净利润-5.99亿美元,同比减少192.20%
市场透视 · 11-28
Arrowhead Pharmaceuticals, Inc.2024财年实现净利润-5.99亿美元,同比减少192.20%
BUZZ-U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
路透中文 · 11-28
BUZZ-U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘急速上涨9.60%报23.07美元
市场透视 · 11-27
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘急速上涨9.60%报23.07美元
嗡嗡声--美国股票走势-惠普、Urban Outfitters、3D Systems
路透中文 · 11-27
嗡嗡声--美国股票走势-惠普、Urban Outfitters、3D Systems
BUZZ-两家券商上调 Arrowhead Pharma 在 Sarepta 交易后的市盈率
路透中文 · 11-27
BUZZ-两家券商上调 Arrowhead Pharma 在 Sarepta 交易后的市盈率
杀疯了!引爆近1000亿!Arrowhead与Sarepta合作开发的siRNA药物绝了
谈思生物 · 11-27
杀疯了!引爆近1000亿!Arrowhead与Sarepta合作开发的siRNA药物绝了
嗡嗡声--美国股票走势-高盛, Zoom, Rumble
路透中文 · 11-27
嗡嗡声--美国股票走势-高盛, Zoom, Rumble
嗡嗡声--美国股票走势-Pinterest、百思买、雪佛龙
Reuters · 11-26
嗡嗡声--美国股票走势-Pinterest、百思买、雪佛龙
BUZZ-与 Sarepta 达成许可协议后,Arrowhead 制药公司业绩大涨
路透中文 · 11-26
BUZZ-与 Sarepta 达成许可协议后,Arrowhead 制药公司业绩大涨
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.18%报19.50美元
市场透视 · 11-25
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.18%报19.50美元
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%报20.12美元
市场透视 · 10-21
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%报20.12美元
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.11%
市场透视 · 10-01
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.11%
BUZZ--美国股票走势-Arrowhead Pharma、波音公司、Centessa Pharma
Reuters · 09-10
BUZZ--美国股票走势-Arrowhead Pharma、波音公司、Centessa Pharma
BUZZ-Arrowhead Pharma 因遗传病疗法的突破性疗法标签而上涨
Reuters · 09-10
BUZZ-Arrowhead Pharma 因遗传病疗法的突破性疗法标签而上涨
Arrowhead Pharmaceuticals, Inc.2024财年第二财季实现净利润-1.71亿美元,同比减少66.02%
自选股智能写手 · 08-18
Arrowhead Pharmaceuticals, Inc.2024财年第二财季实现净利润-1.71亿美元,同比减少66.02%
异动解读 | Arrowhead Pharmaceuticals股价大跌 生物技术股受压
异动解读 · 08-12
异动解读 | Arrowhead Pharmaceuticals股价大跌 生物技术股受压
美国研究综述-Duolingo、Nova、全民健康服务
Reuters · 08-10
美国研究综述-Duolingo、Nova、全民健康服务
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.84%
自选股智能写手 · 08-09
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.84%
加载更多
公司概况
公司名称:
Arrowhead Research Corporation
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立,后在特拉华州重新注册成立。该公司开发药物,通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式,该公司的疗法触发RNA干扰机制,以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。
发行价格:
--
{"stockData":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Research Corporation","latestPrice":20.36,"timestamp":1734555600000,"preClose":22.27,"halted":0,"volume":1399598,"hourTrading":{"tag":"盘前","latestPrice":20.89,"preClose":20.36,"latestTime":"04:33 EST","volume":2,"amount":41.78,"timestamp":1734600821579},"delay":0,"floatShares":110645289,"shares":124434442,"eps":-5.004783,"marketStatus":"盘前交易","marketStatusCode":1,"change":-1.91,"latestTime":"12-19 05:45:14 EST","open":22.27,"high":22.28,"low":20.12,"amount":29210072.12734,"amplitude":0.096991,"askPrice":22.43,"askSize":445,"bidPrice":18.75,"bidSize":533,"shortable":3,"etf":0,"ttmEps":-5.004783,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":740203200000,"adjPreClose":20.36,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":20.89,"preClose":20.36,"latestTime":"04:33 EST","volume":2,"amount":41.78,"timestamp":1734600821579},"postHourTrading":{"tag":"盘后","latestPrice":20.25,"preClose":20.36,"latestTime":"19:37 EST","volume":37127,"amount":755881.2621,"timestamp":1734568641483},"volumeRatio":1.157205294494195,"impliedVol":0.4201,"impliedVolPercentile":0.1952},"requestUrl":"/m/hq/s/ARWR","defaultTab":"news","newsList":[{"id":"2489231647","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.36%报23.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231647?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:01","pubTimestamp":1733497275,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时01分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.36%。截至发稿,该股报23.49美元/股,成交量11.3388万股,换手率0.09%,振幅5.11%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.53%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Dermata Therapeutics Inc C/Wts 、Cardio Diagnostics Holdings Inc.涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为41.96%、33.14%、20.02%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、Aprea Therapeutics, Inc.,振幅分别为27.68%、19.38%、18.99%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230115a1d97f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230115a1d97f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","ARWR"],"gpt_icon":0},{"id":"2489119077","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489119077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489119077?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:29","pubTimestamp":1733329768,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日00时29分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.18%。截至发稿,该股报24.72美元/股,成交量66.5798万股,换手率0.54%,振幅6.19%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃,换手率分别为3184.25%、249.18%、129.90%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.,振幅分别为237.89%、61.31%、55.22%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205002928971ba62a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205002928971ba62a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4588","ARWR"],"gpt_icon":0},{"id":"2486386065","title":"Arrowhead Pharmaceuticals, Inc.2024财年实现净利润-5.99亿美元,同比减少192.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486386065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486386065?lang=zh_cn&edition=full","pubTime":"2024-11-28 07:00","pubTimestamp":1732748440,"startTime":"0","endTime":"0","summary":"11月28日,Arrowhead Pharmaceuticals, Inc.公布财报,公告显示公司2024财年净利润为-5.99亿美元,同比减少192.20%;其中营业收入为3.55百万美元,同比减少98.53%,每股基本收益为-5.00美元。从资产负债表来看,Arrowhead Pharmaceuticals, Inc.总负债9.49亿美元,其中短期债务6.34百万美元,资产负债比为1.21,流动比率为6.75。机构评级:截至2024年11月28日,当前有12家机构对Arrowhead Pharmaceuticals, Inc.目标价做出预测,其中目标均价为44.08美元,其中最低目标价为23.00美元,最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128070046a25ac47e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128070046a25ac47e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"2486879648","title":"BUZZ-U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic","url":"https://stock-news.laohu8.com/highlight/detail?id=2486879648","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486879648?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:10","pubTimestamp":1732723818,"startTime":"0","endTime":"0","summary":"路透社11月27日 - 受科技股下跌拖累,标普 500 指数和纳斯达克指数周三走低,投资者关注美联储在通胀数据持平后的下一步行动。标准普尔500指数.SPX下跌0.43%,报5995.73点;纳斯达克综合指数.IXIC下跌1.04%,报18976.32点。标准普尔 500 指数.PG.INX涨幅前三名是:。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nL3T3MY14R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSE","GROV","ADSK","TBBB","VRSN","FLNC","IDAI","BBY","NTNX","ARWR","VCIG","LGCL","SOS","KRON","SLS","KSS","QD","NRG","GOGL","WDAY","SMRT","DELL","AMGN","STEM","SYM","ALEC","AGL","DDD","PNST","PGHL","SEDG","DD","MLM","OTLK","SJM","ULTA","URBN","DKS","EL","HPQ","LESL"],"gpt_icon":1},{"id":"2486789398","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘急速上涨9.60%报23.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486789398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486789398?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:31","pubTimestamp":1732717914,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时31分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅上涨9.60%。截至发稿,该股报23.07美元/股,成交量10.8204万股,换手率0.09%,振幅3.33%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为793.75%、26.04%、6.89%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Silexion Therapeutics Corp、Elevai Labs, Inc.,振幅分别为13.97%、8.63%、8.20%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223154abe369da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223154abe369da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ARWR","BK4588"],"gpt_icon":0},{"id":"2486824238","title":"嗡嗡声--美国股票走势-惠普、Urban Outfitters、3D Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2486824238","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486824238?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:02","pubTimestamp":1732716131,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nL3T3MY0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","KRON","LU2237443549.SGD","LU1981816686.USD","WDAY","LU0865486749.SGD","ADSK","LU0683600562.USD","BK4551","LU1496350171.SGD","SYM","LU0787776722.HKD","BK4097","89618","IE00BDCRKT87.USD","LU2272731782.SGD","MLM","IE00B0JY6N72.USD","IE00B19Z9Z06.USD","BK1539","BK4528","OTLK","LU0208291251.USD","LU2023250504.SGD","NTNX","LU0976567544.SGD","HPQ","BK4566","LU2257852520.SGD","AMGN","LU0106831901.USD","LU0203347892.USD","ARWR","CRWD","BK4535","LU0543330483.HKD","FLNC","LU0791590937.USD","DDD","URBN","LU0163747925.USD","IE00BFXG1179.USD","BK1119"],"gpt_icon":1},{"id":"2486215468","title":"BUZZ-两家券商上调 Arrowhead Pharma 在 Sarepta 交易后的市盈率","url":"https://stock-news.laohu8.com/highlight/detail?id=2486215468","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486215468?lang=zh_cn&edition=full","pubTime":"2024-11-27 21:27","pubTimestamp":1732714063,"startTime":"0","endTime":"0","summary":"BUZZ-两家券商上调 Arrowhead Pharma 在 Sarepta 交易后的市盈率11月27日 - ** Arrowhead制药公司ARWR.O股价在收盘前上涨6.4%至22.39美元,而SareptaSRPT.O下跌1%至129.40美元。** 杰富瑞和Leerink Partners上调了对ARWR的评级 ,称 与SRPT的许可协议解决了Arrowhead的现金问题 ,使其能够专注于开发心脏代谢疗法。** 杰富瑞称,该交易将 ARWR 的现金流延长至 2028 年,使其 有足够的资源推出治疗罕见代谢紊乱的 plozasiran;将投资回报率提高了 2 美元,至 67 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nL3S3MY0Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4588","IE0009355771.USD","IE00BFTCPJ56.SGD","SIVBQ","IE00BJT1NW94.SGD","ARWR","BK4139","BK4589","SRPT","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4585","BK4207","BK4211"],"gpt_icon":0},{"id":"2486102338","title":"杀疯了!引爆近1000亿!Arrowhead与Sarepta合作开发的siRNA药物绝了","url":"https://stock-news.laohu8.com/highlight/detail?id=2486102338","media":"谈思生物","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486102338?lang=zh_cn&edition=full","pubTime":"2024-11-27 16:06","pubTimestamp":1732694777,"startTime":"0","endTime":"0","summary":"2024年11月26日,Arrowhead Pharmaceuticals与Sarepta Therapeutics宣布达成一项合作协议。根据合作协议,Arrowhead Pharmaceuticals将获得5亿美元的预付款和3.25亿美元的股权投资。此外,在未来五年内,Arrowhead还将收到2.5亿美元的额外付款,以及3亿美元与近期临床试验患者入组相关的里程碑付款。在宣布合作消息的当天,Arrowhead Pharmaceuticals的股价上涨了12%,其市值达到了26亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","CNS","BK4135","BK4139","ARWR","BK4585"],"gpt_icon":0},{"id":"2486087887","title":"嗡嗡声--美国股票走势-高盛, Zoom, Rumble","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087887","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486087887?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:47","pubTimestamp":1732646870,"startTime":"0","endTime":"0","summary":"[.N美国东部时间13:30,道琼斯工业平均指数.DJI下跌0.05%,报44,713.15点;标准普尔500指数.SPX上涨0.38%,报6,010.24点;纳斯达克综合指数.IXIC上涨0.48%,报19,145.57点。标准普尔 500 指数.PG.INX百分比涨幅前三名是: ** NRG Energy Inc NRG.N,上涨 9.1. ** 星座能源公司CEG.OQ,上涨5.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX1L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIOT","SJM","IE0002270589.USD","DVN","MARA","UAL","WWD","LU0050427557.USD","CVX","AMWD","FCX","PINS","RUM","IE00BFTCPJ56.SGD","CPRI","TOYO","VKTX","JBLU","MAC","AMGN","ALEC","SCCO","DKS","EXAS","GS","LU0310800965.SGD","CRC","ALK","LU0203201768.USD","LU0689472784.USD","LU2242646821.SGD","ATRO","LU1988902786.USD","COIN","SLNO","LU1066051498.USD","MAXN","ASPI","APA","ARWR","REPL","LU2023250504.SGD","DAL","HUT","SMTC","LU0278409577.USD","OVV"],"gpt_icon":1},{"id":"2486000091","title":"嗡嗡声--美国股票走势-Pinterest、百思买、雪佛龙","url":"https://stock-news.laohu8.com/highlight/detail?id=2486000091","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486000091?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:53","pubTimestamp":1732636408,"startTime":"0","endTime":"0","summary":"** Astronics Corp : BUZZ - 因发行 1.5 亿美元可转换债券而下跌 ** Soleno Therapeutics Inc : BUZZ - 因FDA延长对遗传性疾病药物的审查而下跌 ** Arrowhead Pharmaceuticals Inc : BUZZ - 与 Sarepta 达成许可协议后跳涨 ** 帝国石油公司 :** Suncor Energy Inc :** Canadian Natural Resources Ltd : BUZZ - 加拿大石油公司在特朗普誓言征收新关税后下跌 ** Capri Holdings Ltd :","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO","REPL","BBY","ATRO","LDOS","QID",".IXIC","EXAS","QLD","RUM","SQQQ","SMTC","WH","KSS","AMWD","WWD","AMGN","VKTX","CVX","DKS","UDOW","MAXN",".SPX","DXD","MAC","ARWR","CPRI","ADI","SJM","ONB","H","EG","PSQ","ALEC","CRC","DJX","F","ASPI","HUT","PINS",".DJI","LLY","PSTX","GM"],"gpt_icon":1},{"id":"2486006769","title":"BUZZ-与 Sarepta 达成许可协议后,Arrowhead 制药公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2486006769","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486006769?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:24","pubTimestamp":1732631070,"startTime":"0","endTime":"0","summary":"11月26日 - ** Arrowhead Pharmaceuticals ARWR.O宣布与Sarepta SRPT.O达成全球许可协议,该公司股价在盘前交易中大涨23.7%,报23.25美元。** ARWR 称与 Sarepta 就多个临床和临床前项目签署了许可与合作协议 ** Sarepta表示,Arrowhead将获得5亿美元的预付款和3.25亿美元的股权投资,同时Sarepta将获得7个项目的独家许可。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX17V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4139","IE0002141913.USD","ARWR","BK4588","SRPT","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2486080237","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.18%报19.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486080237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486080237?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:41","pubTimestamp":1732545704,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时41分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.18%。截至发稿,该股报19.50美元/股,成交量6.976万股,换手率0.06%,振幅3.16%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.65%。其相关个股中,Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Mural Oncology Plc涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为91.29%、70.90%、44.97%,振幅较大的相关个股有Werewolf Therapeutics, Inc.、Kodiak Sciences Inc、Jasper Therapeutics, Inc.,振幅分别为107.37%、106.46%、106.12%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224144a2549247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224144a2549247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2477862740","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%报20.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477862740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477862740?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:02","pubTimestamp":1729522971,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时02分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.03%。截至发稿,该股报20.12美元/股,成交量15.7312万股,换手率0.13%,振幅4.72%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。其相关个股中,Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃,换手率分别为5339.39%、2914.09%、1211.10%,振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为335.84%、157.02%、131.05%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123025198e3d90b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123025198e3d90b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2472379957","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472379957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472379957?lang=zh_cn&edition=full","pubTime":"2024-10-01 22:00","pubTimestamp":1727791210,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日22时00分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.11%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Aditxt, Inc.、Silexion Therapeutics Corp、Sagimet Biosciences Inc. - Series A较为活跃,换手率分别为588.56%、528.83%、94.03%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Bioatla, Inc.,振幅分别为82.42%、48.90%、34.66%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001220011ab6750f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001220011ab6750f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","ARWR"],"gpt_icon":0},{"id":"2466468453","title":"BUZZ--美国股票走势-Arrowhead Pharma、波音公司、Centessa Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2466468453","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466468453?lang=zh_cn&edition=full","pubTime":"2024-09-10 23:59","pubTimestamp":1725983967,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月10日 - 标普500指数和纳斯达克指数周二上涨,多数大盘股上涨,目前市场焦点转向本周晚些时候的关键通胀数据,该数据可能进一步明确美联储9月18日降息的预期幅度。美东时间11:34,道琼斯工业平均指数 下跌0.5%,报40,639.63点。标普500指数 上涨0.17%,报5480.53点;纳斯达克综合指数 上涨0.41%,报16954.15点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH","BA","GE","GM","CRH","WYNN","ALIM","BKR","RBRK","ARWR","RTX","SIRI","KGS",".SPX","NEM","DDM","MNQmain","ASO","QID",".DJI","XOM","UDOW","IONS","AU","DJX","SQQQ","LU",".IXIC","MCK","COP","CVX","NQmain","HPE","PSQ","HES","SDOW","FCX","PSX","VRDN","COR","RLAY","CLF","DOG","F","DXD"],"gpt_icon":1},{"id":"2466709430","title":"BUZZ-Arrowhead Pharma 因遗传病疗法的突破性疗法标签而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2466709430","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466709430?lang=zh_cn&edition=full","pubTime":"2024-09-10 21:01","pubTimestamp":1725973292,"startTime":"0","endTime":"0","summary":"** 联合公司称,目前美国尚未批准治疗 FCS 的药物 ** 截至上次收盘,该股今年累计下跌 28.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4585","ARWR"],"gpt_icon":0},{"id":"2460973570","title":"Arrowhead Pharmaceuticals, Inc.2024财年第二财季实现净利润-1.71亿美元,同比减少66.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460973570","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460973570?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:01","pubTimestamp":1723910476,"startTime":"0","endTime":"0","summary":"8月18日,Arrowhead Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-1.71亿美元,同比减少66.02%;其中营业收入为0.00美元,每股基本收益为-1.38美元。从资产负债表来看,Arrowhead Pharmaceuticals, Inc.总负债5.45亿美元,其中短期债务6.05百万美元,资产负债比为1.63,流动比率为0.05。机构评级:截至2024年8月18日,当前有14家机构对Arrowhead Pharmaceuticals, Inc.目标价做出预测,其中目标均价为47.50美元,其中最低目标价为19.00美元,最高目标价为74.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800015695a163c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800015695a163c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"1144914613","title":"异动解读 | Arrowhead Pharmaceuticals股价大跌 生物技术股受压","url":"https://stock-news.laohu8.com/highlight/detail?id=1144914613","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144914613?lang=zh_cn&edition=full","pubTime":"2024-08-12 01:44","pubTimestamp":1723398273,"startTime":"0","endTime":"0","summary":"8月9日,生物技术公司Arrowhead Pharmaceuticals, Inc.盘中股价大跌5.62%,报24.34美元/股,成交量4.7128万股。该股近期财报显示,公司实现营业收入0美元,净利润亏损1.25亿美元,每股亏损1.02美元。分析人士指出,Arrowhead Pharmaceuticals股价下跌或与公司最新财报业绩不佳有关。投资者对公司未来前景缺乏信心,导致股价大幅下挫。此外,生物技术行业整体表现疲软,也令Arrowhead Pharmaceuticals承压。同行业公司Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.和Entero Therapeutics Inc.当日换手率较高,分别达到33.09%、5.41%和4.90%,反映出资金在生物科技股中流动加快。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"2458169514","title":"美国研究综述-Duolingo、Nova、全民健康服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2458169514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458169514?lang=zh_cn&edition=full","pubTime":"2024-08-10 01:39","pubTimestamp":1723225194,"startTime":"0","endTime":"0","summary":" 路透8月9日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Duolingo、Nova 和 Universal Health Services。要点 * Duolingo Inc :高盛将其评级从 \"卖出 \"上调至 \"中性\"。* An2 Therapeutics Inc :Leerink Partners将目标价从5美元下调至1美元 * An2 Therapeutics Inc :Leerink Partners 将目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOCS","DXC","DUOL","LU1093756325.SGD","LU2249611893.SGD","AXGN","CARG","ASPN","LU2413666004.HKD","BK4116","RCEL","CNC","BK4554","LU0823414551.USD","LU2362541273.HKD","BK4535","SKIN","ARI","BRDG","CYTK","ARHS","BMBL","AKAM","ARRY","EB","AMPL","BRLT","CUBI","WMS","LU1543694498.USD","LAW","BK4178","AVAH","LU0757428866.USD","CTRE","LU2362541513.USD","DDOG","ARWR","ASAN","EGHT","CABA","CHH","IRON","BLDR","BE","ACAD","DNTH","IE00B19Z4B17.USD","CRNC","DOCN"],"gpt_icon":0},{"id":"2458596640","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458596640","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458596640?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:32","pubTimestamp":1723210320,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时32分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.84%。截至发稿,该股报24.34美元/股,成交量4.7128万股,换手率0.04%,振幅1.03%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Adma Biologics Inc涨幅较大,Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为33.09%、5.41%、4.90%,振幅较大的相关个股有Avidity Biosciences, Inc.、Brainstorm Cell Therapeutics Inc.、An2 Therapeutics, Inc.,振幅分别为10.46%、10.21%、9.60%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092132009682573a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092132009682573a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4139","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arrowheadpharma.com","stockEarnings":[{"period":"1week","weight":-0.1043},{"period":"1month","weight":0.0705},{"period":"3month","weight":-0.0369},{"period":"6month","weight":-0.2016},{"period":"1year","weight":-0.3213},{"period":"ytd","weight":-0.3346}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立,后在特拉华州重新注册成立。该公司开发药物,通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式,该公司的疗法触发RNA干扰机制,以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.005728},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002685},{"month":3,"riseRate":0.55,"avgChangeRate":0.072176},{"month":4,"riseRate":0.45,"avgChangeRate":0.022654},{"month":5,"riseRate":0.35,"avgChangeRate":0.000886},{"month":6,"riseRate":0.6,"avgChangeRate":0.025465},{"month":7,"riseRate":0.6,"avgChangeRate":0.057144},{"month":8,"riseRate":0.4,"avgChangeRate":-0.005854},{"month":9,"riseRate":0.5,"avgChangeRate":0.039058},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.040731},{"month":11,"riseRate":0.52381,"avgChangeRate":0.052244},{"month":12,"riseRate":0.428571,"avgChangeRate":0.047997}],"exchange":"NASDAQ","name":"Arrowhead Research Corporation","nameEN":"Arrowhead Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arrowhead Research Corporation,ARWR,Arrowhead Research Corporation股票,Arrowhead Research Corporation股票老虎,Arrowhead Research Corporation股票老虎国际,Arrowhead Research Corporation行情,Arrowhead Research Corporation股票行情,Arrowhead Research Corporation股价,Arrowhead Research Corporation股市,Arrowhead Research Corporation股票价格,Arrowhead Research Corporation股票交易,Arrowhead Research Corporation股票购买,Arrowhead Research Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}